Hayward, CA, United States of America

Sirika Pillay

This inventor holds 1 USPTO granted patent. Top assignees: Leland Stanford Junior University, Oregon Health & Science University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sirika Pillay: Innovator in AAV Infection Modulation

Introduction

Sirika Pillay is a notable inventor based in Hayward, CA (US). She has made significant contributions to the field of molecular biology, particularly in the modulation of adeno-associated virus (AAV) infection. Her innovative work has implications for gene therapy and other medical applications.

Latest Patents

Sirika Pillay holds 1 patent titled "Methods and compositions for modulating AAV infection." This patent provides compositions and methods for enhancing or reducing the permissiveness of target cells to AAV infection. The methods include increasing levels of AAVR (KIAA0319L) in the cell to enhance infection or reducing AAVR levels to decrease infection. Additionally, the patent outlines techniques for nucleic acid delivery using AAV particles.

Career Highlights

Throughout her career, Sirika Pillay has worked with prestigious institutions such as Leland Stanford Junior University and Oregon Health & Science University. Her research has focused on advancing the understanding of viral infections and their modulation, contributing to the development of innovative therapeutic strategies.

Collaborations

Sirika has collaborated with esteemed colleagues, including Jan E Carette and Andreas Puschnik. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.

Conclusion

Sirika Pillay's contributions to the modulation of AAV infection highlight her role as a leading inventor in the field of molecular biology. Her work not only advances scientific knowledge but also paves the way for future innovations in gene therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…